Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner

Atsushi Hirao, Alison Cheung, Gordon Duncan, Pierre Marie Girard, Andrew J. Elia, Andrew Wakeham, Hitoshi Okada, Talin Sarkissian, Jorge A. Wong, Takashi Sakai, Elisa De Stanchina, Robert G. Bristow, Toshio Suda, Scott W. Lowe, Penny A. Jeggo, Stephen J. Elledge, Tak W. Mak

Research output: Contribution to journalArticle

285 Citations (Scopus)

Abstract

In response to ionizing radiation (IR), the tumor suppressor p53 is stabilized and promotes either cell cycle arrest or apoptosis. Chk2 activated by IR contributes to this stabilization, possibly by direct phosphorylation. Like p53, Chk2 is mutated in patients with Li-Fraumeni syndrome. Since the ataxia telangiectasia mutated (ATM) gene is required for IR-induced activation of Chk2, it has been assumed that ATM and Chk2 act in a linear pathway leading to p53 activation. To clarify the role of Chk2 in tumorigenesis, we generated genetargeted Chk2-deficient mice. Unlike ATM-/- and p53-/- mice, Chk2-/- mice do not spontaneously develop tumors, although Chk2 does suppress 7,12-dimethylbenzanthracene-induced skin tumors. Tissues from Chk2-/- mice, including those from the thymus, central nervous system, fibroblasts, epidermis, and hair follicles, show significant defects in IR-induced apoptosis or impaired G1/S arrest. Quantitative comparison of the G1/S checkpoint, apoptosis, and expression of p53 proteins in Chk2-/- versus ATM-/- thymocytes suggested that Chk2 can regulate p53-dependent apoptosis in an ATM-independent manner. IR-induced apoptosis was restored in Chk2-/- thymocytes by reintroduction of the wild-type Chk2 gene but not by a Chk2 gene in which the sites phosphorylated by ATM and ataxia telangiectasia and rad3+ related (ATR) were mutated to alanine. ATR may thus selectively contribute to p53-mediated apoptosis. These data indicate that distinct pathways regulate the activation of p53 leading to cell cycle arrest or apoptosis.

Original languageEnglish
Pages (from-to)6521-6532
Number of pages12
JournalMolecular and Cellular Biology
Volume22
Issue number18
DOIs
Publication statusPublished - 2002 Sep

Fingerprint

Ataxia Telangiectasia
Apoptosis
Ionizing Radiation
Neoplasms
Thymocytes
Cell Cycle Checkpoints
Li-Fraumeni Syndrome
Genes
9,10-Dimethyl-1,2-benzanthracene
Hair Follicle
Epidermis
Alanine
Thymus Gland
Carcinogenesis
Central Nervous System
Fibroblasts
Phosphorylation
Skin

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cell Biology

Cite this

Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner. / Hirao, Atsushi; Cheung, Alison; Duncan, Gordon; Girard, Pierre Marie; Elia, Andrew J.; Wakeham, Andrew; Okada, Hitoshi; Sarkissian, Talin; Wong, Jorge A.; Sakai, Takashi; De Stanchina, Elisa; Bristow, Robert G.; Suda, Toshio; Lowe, Scott W.; Jeggo, Penny A.; Elledge, Stephen J.; Mak, Tak W.

In: Molecular and Cellular Biology, Vol. 22, No. 18, 09.2002, p. 6521-6532.

Research output: Contribution to journalArticle

Hirao, A, Cheung, A, Duncan, G, Girard, PM, Elia, AJ, Wakeham, A, Okada, H, Sarkissian, T, Wong, JA, Sakai, T, De Stanchina, E, Bristow, RG, Suda, T, Lowe, SW, Jeggo, PA, Elledge, SJ & Mak, TW 2002, 'Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner', Molecular and Cellular Biology, vol. 22, no. 18, pp. 6521-6532. https://doi.org/10.1128/MCB.22.18.6521-6532.2002
Hirao, Atsushi ; Cheung, Alison ; Duncan, Gordon ; Girard, Pierre Marie ; Elia, Andrew J. ; Wakeham, Andrew ; Okada, Hitoshi ; Sarkissian, Talin ; Wong, Jorge A. ; Sakai, Takashi ; De Stanchina, Elisa ; Bristow, Robert G. ; Suda, Toshio ; Lowe, Scott W. ; Jeggo, Penny A. ; Elledge, Stephen J. ; Mak, Tak W. / Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner. In: Molecular and Cellular Biology. 2002 ; Vol. 22, No. 18. pp. 6521-6532.
@article{09e672d22e42442bb6e87beb8497433c,
title = "Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner",
abstract = "In response to ionizing radiation (IR), the tumor suppressor p53 is stabilized and promotes either cell cycle arrest or apoptosis. Chk2 activated by IR contributes to this stabilization, possibly by direct phosphorylation. Like p53, Chk2 is mutated in patients with Li-Fraumeni syndrome. Since the ataxia telangiectasia mutated (ATM) gene is required for IR-induced activation of Chk2, it has been assumed that ATM and Chk2 act in a linear pathway leading to p53 activation. To clarify the role of Chk2 in tumorigenesis, we generated genetargeted Chk2-deficient mice. Unlike ATM-/- and p53-/- mice, Chk2-/- mice do not spontaneously develop tumors, although Chk2 does suppress 7,12-dimethylbenzanthracene-induced skin tumors. Tissues from Chk2-/- mice, including those from the thymus, central nervous system, fibroblasts, epidermis, and hair follicles, show significant defects in IR-induced apoptosis or impaired G1/S arrest. Quantitative comparison of the G1/S checkpoint, apoptosis, and expression of p53 proteins in Chk2-/- versus ATM-/- thymocytes suggested that Chk2 can regulate p53-dependent apoptosis in an ATM-independent manner. IR-induced apoptosis was restored in Chk2-/- thymocytes by reintroduction of the wild-type Chk2 gene but not by a Chk2 gene in which the sites phosphorylated by ATM and ataxia telangiectasia and rad3+ related (ATR) were mutated to alanine. ATR may thus selectively contribute to p53-mediated apoptosis. These data indicate that distinct pathways regulate the activation of p53 leading to cell cycle arrest or apoptosis.",
author = "Atsushi Hirao and Alison Cheung and Gordon Duncan and Girard, {Pierre Marie} and Elia, {Andrew J.} and Andrew Wakeham and Hitoshi Okada and Talin Sarkissian and Wong, {Jorge A.} and Takashi Sakai and {De Stanchina}, Elisa and Bristow, {Robert G.} and Toshio Suda and Lowe, {Scott W.} and Jeggo, {Penny A.} and Elledge, {Stephen J.} and Mak, {Tak W.}",
year = "2002",
month = "9",
doi = "10.1128/MCB.22.18.6521-6532.2002",
language = "English",
volume = "22",
pages = "6521--6532",
journal = "Molecular and Cellular Biology",
issn = "0270-7306",
publisher = "American Society for Microbiology",
number = "18",

}

TY - JOUR

T1 - Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner

AU - Hirao, Atsushi

AU - Cheung, Alison

AU - Duncan, Gordon

AU - Girard, Pierre Marie

AU - Elia, Andrew J.

AU - Wakeham, Andrew

AU - Okada, Hitoshi

AU - Sarkissian, Talin

AU - Wong, Jorge A.

AU - Sakai, Takashi

AU - De Stanchina, Elisa

AU - Bristow, Robert G.

AU - Suda, Toshio

AU - Lowe, Scott W.

AU - Jeggo, Penny A.

AU - Elledge, Stephen J.

AU - Mak, Tak W.

PY - 2002/9

Y1 - 2002/9

N2 - In response to ionizing radiation (IR), the tumor suppressor p53 is stabilized and promotes either cell cycle arrest or apoptosis. Chk2 activated by IR contributes to this stabilization, possibly by direct phosphorylation. Like p53, Chk2 is mutated in patients with Li-Fraumeni syndrome. Since the ataxia telangiectasia mutated (ATM) gene is required for IR-induced activation of Chk2, it has been assumed that ATM and Chk2 act in a linear pathway leading to p53 activation. To clarify the role of Chk2 in tumorigenesis, we generated genetargeted Chk2-deficient mice. Unlike ATM-/- and p53-/- mice, Chk2-/- mice do not spontaneously develop tumors, although Chk2 does suppress 7,12-dimethylbenzanthracene-induced skin tumors. Tissues from Chk2-/- mice, including those from the thymus, central nervous system, fibroblasts, epidermis, and hair follicles, show significant defects in IR-induced apoptosis or impaired G1/S arrest. Quantitative comparison of the G1/S checkpoint, apoptosis, and expression of p53 proteins in Chk2-/- versus ATM-/- thymocytes suggested that Chk2 can regulate p53-dependent apoptosis in an ATM-independent manner. IR-induced apoptosis was restored in Chk2-/- thymocytes by reintroduction of the wild-type Chk2 gene but not by a Chk2 gene in which the sites phosphorylated by ATM and ataxia telangiectasia and rad3+ related (ATR) were mutated to alanine. ATR may thus selectively contribute to p53-mediated apoptosis. These data indicate that distinct pathways regulate the activation of p53 leading to cell cycle arrest or apoptosis.

AB - In response to ionizing radiation (IR), the tumor suppressor p53 is stabilized and promotes either cell cycle arrest or apoptosis. Chk2 activated by IR contributes to this stabilization, possibly by direct phosphorylation. Like p53, Chk2 is mutated in patients with Li-Fraumeni syndrome. Since the ataxia telangiectasia mutated (ATM) gene is required for IR-induced activation of Chk2, it has been assumed that ATM and Chk2 act in a linear pathway leading to p53 activation. To clarify the role of Chk2 in tumorigenesis, we generated genetargeted Chk2-deficient mice. Unlike ATM-/- and p53-/- mice, Chk2-/- mice do not spontaneously develop tumors, although Chk2 does suppress 7,12-dimethylbenzanthracene-induced skin tumors. Tissues from Chk2-/- mice, including those from the thymus, central nervous system, fibroblasts, epidermis, and hair follicles, show significant defects in IR-induced apoptosis or impaired G1/S arrest. Quantitative comparison of the G1/S checkpoint, apoptosis, and expression of p53 proteins in Chk2-/- versus ATM-/- thymocytes suggested that Chk2 can regulate p53-dependent apoptosis in an ATM-independent manner. IR-induced apoptosis was restored in Chk2-/- thymocytes by reintroduction of the wild-type Chk2 gene but not by a Chk2 gene in which the sites phosphorylated by ATM and ataxia telangiectasia and rad3+ related (ATR) were mutated to alanine. ATR may thus selectively contribute to p53-mediated apoptosis. These data indicate that distinct pathways regulate the activation of p53 leading to cell cycle arrest or apoptosis.

UR - http://www.scopus.com/inward/record.url?scp=0036724625&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036724625&partnerID=8YFLogxK

U2 - 10.1128/MCB.22.18.6521-6532.2002

DO - 10.1128/MCB.22.18.6521-6532.2002

M3 - Article

VL - 22

SP - 6521

EP - 6532

JO - Molecular and Cellular Biology

JF - Molecular and Cellular Biology

SN - 0270-7306

IS - 18

ER -